VRAX
Virax Biolabs Group·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-21
Latest data update time: Updated on 2026-03-21
2.54 / 10Overall Score
UnderperformInvestment Rating
2.54 / 10Overall Score
UnderperformInvestment Rating
Trend Analysis of VRAX
- Based on a composite score of 2.54/10, we rate VRAX as a Underperform. Our analysis breaks down into 0.46/10 for Fundamentals, 2.62/10 for Technicals, and 3.54/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Technical Analysis of VRAX?
Is VRAX undervalued or overvalued?
Is money flowing into or out of VRAX?
Trend Analysis of VRAX
- Based on a composite score of 2.54/10, we rate VRAX as a Underperform. Our analysis breaks down into 0.46/10 for Fundamentals, 2.62/10 for Technicals, and 3.54/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is VRAX undervalued or overvalued?
Technical Analysis of VRAX?
Is money flowing into or out of VRAX?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
